BF
CPRX

BOK Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

BOK Financial’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$485K Sell
19,585
-1,808
-8% -$43.1K 0.01% 543
2025
Q4 		$499K Sell
21,393
-113
-0.5% -$2.52K 0.01% 546
2025
Q3 		$424K Sell
21,506
-30
-0.1% -$617 0.01% 597
2025
Q2 		$467K Sell
21,536
-1,049
-5% -$24.8K 0.01% 587
2025
Q1 		$548K Sell
22,585
-1,963
-8% -$44.2K 0.01% 537
2024
Q4 		$538K Sell
24,548
-3,636
-13% -$78.1K 0.01% 544
2024
Q3 		$560K Buy
+28,184
New +$522K 0.01% 542

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

BOK Financial's CPRX Position: Q1 2026 in Review

BOK Financial reduced its Catalyst Pharmaceutical (CPRX) stake by 8.5% in Q1 2026, selling an estimated $43.1K and leaving 19,585 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #543.

BOK Financial first reported a position in CPRX in Q3 2024 and has held it in 7 quarters since. The position peaked at $560K in Q3 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • BOK Financial held 19,585 shares of Catalyst Pharmaceutical worth $485K as of Q1 2026.
  • BOK Financial sold 1,808 Catalyst Pharmaceutical shares in Q1 2026, an estimated $43.1K.
  • Catalyst Pharmaceutical made up 0.01% of BOK Financial's portfolio in Q1 2026, its #543 holding.
  • BOK Financial first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 7 quarters since.
  • BOK Financial's Catalyst Pharmaceutical position peaked at $560K in Q3 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.